Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Jan;9(1):1-2.
doi: 10.1007/s13238-017-0488-1.

"Magic Bullets" at the center stage of immune therapy: a special issue on therapeutic antibodies

Zhiqiang An  1
Affiliations
Editorial

"Magic Bullets" at the center stage of immune therapy: a special issue on therapeutic antibodies

Zhiqiang An. Protein Cell. 2018 Jan.
No abstract available

PubMed Disclaimer

References

    1. An Z. Therapeutic monoclonal antibodies: from bench to clinic. Wiley: Hoboken; 2009.
    1. An Z. Monoclonal antibodies—a proven and rapidly expanding therapeutic modality for human diseases. Protein Cell. 2010;1:319–330. doi: 10.1007/s13238-010-0052-8. - DOI - PMC - PubMed
    1. Bardwell PD, Staron MM, Liu J, Tao Q, Scesney S, Bukofzer G, Rodriguez LE, Choi CH, Wang J, Chang Q, et al. Potent and conditional redirected T cell killing of tumor cells using Half DVD-Ig. Protein Cell. 2017;9:121–129. doi: 10.1007/s13238-017-0429-z. - DOI - PMC - PubMed
    1. Emmons C, Hunsicker LG. Muromonab-CD3 (Orthoclone OKT3): the first monoclonal antibody approved for therapeutic use. Iowa Med. 1987;77:78–82. - PubMed
    1. Kang C, Xia L, Chen Y, Zhang T, Wang Y, Zhou B, You M, Yuan Q, Tzeng CM, An Z, et al. A novel therapeutic anti-HBV antibody with increased binding to human FcRn improves in vivo PK in mice and monkeys. Protein Cell. 2017;9:130–134. doi: 10.1007/s13238-017-0438-y. - DOI - PMC - PubMed

Publication types

Substances